Niagara is a modern autoflowering strain developed from Lowryder genetics. Designed for simplicity and accessibility in both indoor and outdoor cultivation, this variety maintains a short 75-day flowering cycle. While it is characterized by a low yield, its ease of growth makes it a practical selection for cultivators seeking a concise, automated life cycle. Its genetic lineage has further expanded through hybridization, most notably in the creation of its offspring, Niagara x Shiva.

The sensory profile of Niagara is defined by a complex terpene hierarchy led by caryophyllene and nerolidol, followed by humulene, limonene, myrcene, linalool, beta-pinene, and pinene. This specific arrangement of aromatic compounds creates a distinct chemical signature that informs the strain’s overall profile. These terpenes work in concert to define the nuanced essence of the flower, ensuring a profile that is chemically diverse and analytically consistent.

As a THC-dominant variety, Niagara is sought after for its specific physiological impact, which is primarily described as relaxed, happy, and uplifted. These characteristics make it a functional candidate for users looking to manage stress and pain, or to facilitate the onset of sleep. Its balanced effects and straightforward cultivation requirements consolidate its reputation as a reliable, modern genetic option for both medicinal use and personal gardening.